Transdermal delivery system for dried particulate or...

Details Transdermal delivery system for dried particulate or... Transdermal delivery system for dried particulate or...

2006-10-17

2010-02-16

Nashed, Nashaat T (Department: 1656)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

C604S020000, C530S303000, C600S372000

Reexamination Certificate

active

07662404

ABSTRACT:
The present invention provides a system for transdermal delivery of dried or lyophilized pharmaceutical compositions and methods using thereof. The system comprises an apparatus for facilitating transdermal delivery of a peptide or polypeptide that generates hydrophilic micro-channels, and a patch comprising dried therapeutically peptide or polypeptide. Particularly, the system of the present invention facilitates transdermal delivery of parathyroid hormone useful for preventing or treating bone disorders.

REFERENCES:
patent: 3964482 (1976-06-01), Gerstel et al.
patent: 4915950 (1990-04-01), Miranda et al.
patent: 5019034 (1991-05-01), Weaver et al.
patent: 5158537 (1992-10-01), Haak et al.
patent: H1160 (1993-04-01), Maulding et al.
patent: 5230898 (1993-07-01), Horstmann et al.
patent: 5445609 (1995-08-01), Lattin et al.
patent: 5611806 (1997-03-01), Jang
patent: 5618265 (1997-04-01), Myers et al.
patent: 5681580 (1997-10-01), Jang et al.
patent: 5685837 (1997-11-01), Horstmann
patent: 5807306 (1998-09-01), Shapland et al.
patent: 5885211 (1999-03-01), Eppstein et al.
patent: 5928571 (1999-07-01), Chan
patent: 5944685 (1999-08-01), Muroki
patent: 5958447 (1999-09-01), Haralambopoulos et al.
patent: 5983130 (1999-11-01), Phipps et al.
patent: 5983135 (1999-11-01), Avrahami
patent: 6002961 (1999-12-01), Mitragotri et al.
patent: 6022316 (2000-02-01), Eppstein
patent: 6050988 (2000-04-01), Zuck
patent: 6142939 (2000-11-01), Eppstein et al.
patent: 6148232 (2000-11-01), Avrahami
patent: 6169920 (2001-01-01), Haak et al.
patent: 6173202 (2001-01-01), Eppstein
patent: 6219577 (2001-04-01), Brown, III et al.
patent: 6274166 (2001-08-01), Sintov et al.
patent: 6274582 (2001-08-01), Mårin
patent: 6317629 (2001-11-01), Haak et al.
patent: 6328033 (2001-12-01), Avrahami
patent: 6335030 (2002-01-01), Hoeck et al.
patent: 6522918 (2003-02-01), Crisp et al.
patent: 6526316 (2003-02-01), Iga et al.
patent: 6597946 (2003-07-01), Avrahami et al.
patent: 6611706 (2003-08-01), Avrahami et al.
patent: 6615079 (2003-09-01), Avrahami
patent: 6622037 (2003-09-01), Kasano
patent: 6662044 (2003-12-01), Crawford et al.
patent: 6708060 (2004-03-01), Avrahami et al.
patent: 6711435 (2004-03-01), Avrahami
patent: 7062317 (2006-06-01), Avrahami et al.
patent: 7123957 (2006-10-01), Avrahami
patent: 7164942 (2007-01-01), Avrahami et al.
patent: 2002/0010414 (2002-01-01), Coston et al.
patent: 2002/0038101 (2002-03-01), Avrahami et al.
patent: 2002/0058936 (2002-05-01), Avrahami et al.
patent: 2003/0139731 (2003-07-01), Marchitto et al.
patent: 2003/0204163 (2003-10-01), Marchitto et al.
patent: 2004/0059282 (2004-03-01), Flock et al.
patent: 2005/0119605 (2005-06-01), Sohn
patent: 0912239 (1990-03-01), None
patent: 0413487 (1991-02-01), None
patent: 0912239 (2001-09-01), None
patent: WO 97/07734 (1997-03-01), None
patent: WO 98/08492 (1998-03-01), None
patent: WO 00/27473 (2000-05-01), None
patent: WO 02/085451 (2002-10-01), None
patent: WO 02/091934 (2002-11-01), None
patent: WO 02/092163 (2002-11-01), None
patent: WO 03/039620 (2003-05-01), None
patent: WO 03/089043 (2003-10-01), None
patent: WO 2006/131931 (2006-12-01), None
P. Singh et al, Modelling of plasma levels of drugs following transdermal iontophoresis, Journal of Controlled Release, Elsevier Science, vol. 33 , pp. 293-298 (1995).
David T.-W. Lau et al., Effect of Current Magnitude and Drug Concentration on Iontophoretic Delivery of Octreotide Acetate (Sandostatin®) in the Rabbit; Pharmaceutical Research, vol. 11, No. 12, pp. 1742-1746 (1994).
Saran Kumar et al., “In vivo transdermal iontophoretic delivery of growth hormone releasing factor GRF (1-44) in hairless guinea pigs”, Elsevier Science, Journal of Cont rolled Release, vol. 18, pp. 213-220 (1992).
Harma Ellens et al., Transdermal iontophoretic delivery of [3H]GHRP in rats, International Journal of Pharmaceutics, vol. 159, pp. 1-11(1997).
Yuri A. Chizmadzhev et al.,“Electrical Properties of Skin at Moderate Voltages: Contribution of Appendageal Macropores”, Biophysical Journal, vol. 74, pp. 843-856 (1998).
Sintov et al., “Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs,” Journal of Controlled Release 89: 311-320 (2003).

Affiliated with

Also associated with

Rating

Transdermal delivery system for dried particulate or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal delivery system for dried particulate or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery system for dried particulate or... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4207106